Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
RecruitingNCT06039176Phase: Not specifiedStarted 2023-10-27
Summary
Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to no
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
100 Years
Locations
UCSFSan Francisco, California, United States
University of FloridaGainesville, Florida, United States
University of ChicagoChicago, Illinois, United States
University of Kansas Medical CenterKansas City, Kansas, United States
Mayo Clinic-RochesterRochester, Minnesota, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06039176